New Delhi: Russia's approval of the antiviral drug Avifavir to treat COVID-19 is good news for India as it is based on an influenza medic...Read More
By FPJ Web Desk
While the world is still researching on COVID-19 vaccine, Russia is all set to give its first approved drug to treat COVID-19 patients st...Read More
If the drug is commercialised in India, it will be marketed under the brand name ‘FabiFlu’.
According to the researchers, treatment involving combination of the drugs interferon beta-1b, plus the antiviral therapy lopinavir-riton...Read More
By FPJ Bureau
New Delhi: Awfully tough to sort out fact from rumor about the flu. Elodie Ghedin of the New York University’s Center for Genomics and Sy...Read More